"I missed my dose — should I just take two next time?"
It's one of the most frequent calls a clinic running a peptide or GLP program will receive. And it's one of the most consequential to handle well.
Because here's the truth: missing a dose almost never undoes a patient's progress. But reacting to a missed dose incorrectly can. The risk isn't the gap in the schedule — it's the well-intentioned attempt to "fix it" that follows.
How a clinic handles this question, and how clearly that guidance reaches the patient before the moment of confusion, is one of the quiet markers of a well-structured program.
What Actually Happens When a Dose Is Missed
Peptides and GLP-based therapies are designed to work over time.
They aren't stimulants. They don't rely on a single dose to "kick in" or produce a noticeable effect. They function as ongoing signals to the body's natural systems — and the body responds to the cumulative pattern, not to any individual injection.
This means one missed dose, in most cases, does not erase progress. The signal pathway doesn't reset. The protocol doesn't have to start over. The body doesn't forget the work that's been done over the previous weeks.
What matters is the overall consistency of the program — not the response to one off-schedule moment.
Patients who understand this stay calm when something disrupts their routine. Patients who don't tend to overcorrect, often in ways that cause real problems.
What Patients Should Actually Do
The guidance is simpler than most patients expect.
If a dose is missed:
- Do not double the next injection unless a provider has specifically directed it
- Return to the normal dosing schedule as soon as possible
- Avoid making reactive adjustments independently
If more than a few days have passed since the missed dose — or if there's any uncertainty about what to do next — the patient should reach out to the provider before making any changes.
That's it. The instinct to "make up for it" is exactly the instinct that creates problems. The right move is almost always to resume the protocol as written, not to compensate for what was missed.
Did You Know?
Most adverse events in peptide and GLP programs don't come from the prescribed protocol. They come from patients adjusting the protocol on their own — usually in response to a missed dose, an unexpected reaction, or a result that didn't arrive as quickly as they hoped.
Why Doubling Doses Causes More Problems Than Missing Them
The temptation to double a dose comes from a reasonable instinct: if one dose was missed, taking two should balance things out.
The math works on paper. The biology doesn't.
Doubling a dose can:
- Trigger side effects the patient otherwise wouldn't experience
- Disrupt the steady-state effect the protocol was designed to build
- Create a confusing data point when the next reassessment happens
- Lead the patient to conclude the peptide "doesn't agree with them" when the actual issue was the self-adjustment
The downstream cost of one doubled dose is often weeks of unnecessary discomfort, lost trust in the program, and patients who quietly drop off before the protocol has a chance to deliver real results.
Structured use will always outperform reactive changes.
Why This Conversation Belongs in Every Patient Onboarding
The clinics that handle missed doses well are the ones that addressed the question before it ever came up.
Strong patient onboarding includes clear, written guidance on:
What to Do If a Dose Is Missed
Plain-language instructions the patient can reference without calling the front desk. The information lives in the materials they go home with — not only in the consult they may not fully remember.
When to Contact the Provider
Defined thresholds for when self-management is appropriate and when it's time to reach out. Patients shouldn't have to guess where the line is.
What "Consistency" Actually Means
Patients often interpret consistency as perfection. The clinic's job is to reframe it as the long-term pattern — and to give patients permission to be human within a structured protocol.
Why Self-Adjustment Is Discouraged
The reasoning, briefly explained. Patients who understand why they shouldn't double doses are far more likely to follow the guidance than patients who were simply told not to.
Reality Check
Most of the panic-driven calls about missed doses happen because the patient doesn't have written guidance to fall back on. When the answer lives only in a verbal consult, the answer disappears the moment the patient leaves the clinic.
Where Most Programs Get This Wrong
The clinics that struggle with patient adherence in peptide programs share a common pattern:
- Missed-dose guidance is delivered verbally and never documented
- Patients are left to interpret what "consistency" means on their own
- The clinic fields the same question repeatedly because the answer never made it into patient materials
- Self-adjustment goes unaddressed until something goes wrong
- Reassessments don't capture which patients have been quietly modifying their protocols
None of these are clinical failures. All of them are communication and structure failures — which makes them entirely solvable.
The Bigger Picture: Consistency Over Perfection
The goal of a well-built peptide program isn't perfect adherence. It's sustained engagement.
Patients are going to miss doses. They're going to travel, get sick, run out of supplies, forget the schedule, or simply have a week that doesn't go to plan. That's reality — and the program needs to be designed for it.
Programs built on perfection break the moment a patient deviates. Programs built on consistency absorb the deviation, return the patient to the protocol, and keep the trajectory intact.
When the protocol is followed correctly, and adjustments are made intentionally rather than reactively, the outcomes get better. Side effects decrease. Progress becomes more predictab